Elanco Animal Health Incorporated Depreciation
Elanco Animal Health Incorporated (ELAN) reported Depreciation of $26.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-05
- Elanco Animal Health Incorporated depreciation for the quarter ending 2026-06-30 was $26.00M, a 4.00% increase year-over-year.
- Elanco Animal Health Incorporated depreciation for the quarter ending 2026-03-31 was $28.00M, a 16.67% increase year-over-year.
- Elanco Animal Health Incorporated depreciation for the quarter ending 2025-09-30 was $28.00M, a 3.70% increase year-over-year.
- Elanco Animal Health Incorporated depreciation for the quarter ending 2025-06-30 was $25.00M, a 13.64% increase year-over-year.
- Elanco Animal Health Incorporated depreciation for fiscal 2024 was $95.00M, a 3.26% increase from fiscal 2023.
- Elanco Animal Health Incorporated depreciation for fiscal 2023 was $92.00M, a 3.37% increase from fiscal 2022.
- Elanco Animal Health Incorporated depreciation for fiscal 2022 was $89.00M, a 17.59% decline from fiscal 2021.
- Elanco Animal Health Incorporated depreciation for fiscal 2021 was $108.00M, a 11.48% decline from fiscal 2020.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $26.00M 10-Q · filed 2026-08-05 | $54.00M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $28.00M 10-Q · filed 2026-05-06 | ||||
| 2025-09-30 | $28.00M 10-Q · filed 2025-11-05 | $53.00M derived: sum of 2 quarters · filed 2026-08-05 | $77.00M 10-Q · filed 2025-11-05 | $101.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $25.00M 10-Q · filed 2026-08-05 | $49.00M 10-Q · filed 2026-08-05 | $73.00M derived: sum of 3 quarters · filed 2026-08-05 | $100.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $24.00M 10-Q · filed 2026-05-06 | $48.00M derived: sum of 2 quarters · filed 2026-05-06 | $75.00M derived: sum of 3 quarters · filed 2026-05-06 | $97.00M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $51.00M derived: sum of 2 quarters · filed 2025-11-05 | $73.00M derived: sum of 3 quarters · filed 2025-11-05 | $95.00M 10-K · filed 2025-02-25 | |
| 2024-09-30 | $27.00M 10-Q · filed 2025-11-05 | $49.00M derived: sum of 2 quarters · filed 2025-11-05 | $71.00M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $22.00M 10-Q · filed 2025-08-07 | $44.00M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $22.00M 10-Q · filed 2025-05-07 | ||||
| 2023-12-31 | $92.00M 10-K · filed 2025-02-25 | ||||
| 2022-12-31 | $89.00M 10-K · filed 2025-02-25 | ||||
| 2021-12-31 | $108.00M 10-K · filed 2024-02-26 | ||||
| 2020-12-31 | $122.00M 10-K · filed 2023-03-01 | ||||
| 2019-12-31 | $94.00M 10-K · filed 2022-02-28 | $93.70M 10-K · filed 2020-02-28 | |||
| 2018-12-31 | $81.30M 10-K · filed 2021-03-01 | ||||
| 2017-12-31 | $79.80M 10-K · filed 2020-02-28 | ||||
| 2016-12-31 | $75.70M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |